福辛普利联合吲哒帕胺治疗原发性高血压临床研究

Clinical Analysis of Essential Hypertension Treated by Fosinopril combined with Indapamide

目的:探讨福辛普利联合吲哒帕胺治疗原发性高血压的临床疗效。方法:对2007年1月至2007年12月就诊的85例原发性高血压患者随机分为联合治疗组(n=43)与单纯治疗组(n=42),联合治疗组应用福辛普利和吲哒帕胺降压,单纯治疗组仅用吲哒帕胺治疗,对比分析二种治疗方法对原发性高血压的降压疗效。结果:联合治疗组治疗原发性高血压的有效率97.6%明显高于单纯治疗组的80.9%,P<0.05。结论:福辛普利联合吲哒帕胺治疗原发性高血压降压效果好,适合在临床中推广应用。

Objective:To study the clinical effect of essential hypertension treated by Fosinopril combined with Indapamide.Methods:85 patients with essential hypertension were randomly divided into two groups from Jan 2007 to Dec 2007,one was combination therapy group (n=43),the other was simple therapy group (n=42).The combination therapy group was treated by Fosinopril and Indapamide,and the simple therapy group was treated by Indapamide only.Results:The total rate of curative efficacy was significantly higher in the combination therapy group (97.6%)than that in the simple therapy group (80.9%),P < 0.05.Conclusions:The ideal effectiveness of essential hypertension treated by Fosinopril combined with Indapamide was satisfied.The combination drug therapy is worthy to spread in clinic.